446 related articles for article (PubMed ID: 31665214)
21. A Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver Cancer.
Guo C; Zhou J; Ma B; Wang R; Ge Y; Wang Z; Ji B; Wang W; Zhang J; Wang Z
Front Surg; 2021; 8():724792. PubMed ID: 34504866
[No Abstract] [Full Text] [Related]
22. The lncRNA Signatures of Genome Instability to Predict Survival in Patients with Renal Cancer.
Huang L; Xie Y; Jiang S; Han W; Zeng F; Li D
J Healthc Eng; 2021; 2021():1090698. PubMed ID: 34917302
[TBL] [Abstract][Full Text] [Related]
23. Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
Bradford JR; Cox A; Bernard P; Camp NJ
PLoS One; 2016; 11(9):e0163238. PubMed ID: 27685983
[TBL] [Abstract][Full Text] [Related]
24. Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer.
Zhu X; Yu R; Peng Y; Miao Y; Jiang K; Li Q
Front Genet; 2022; 13():990661. PubMed ID: 36118868
[No Abstract] [Full Text] [Related]
25. Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer.
Yin T; Zhao D; Yao S
Front Genet; 2021; 12():679150. PubMed ID: 34163531
[TBL] [Abstract][Full Text] [Related]
26. Development of a Genomic Instability-Derived lncRNAs-Based Risk Signature as a Predictor of Prognosis for Endometrial Cancer.
Wang X; Ye L; Li B
J Cancer; 2022; 13(7):2213-2225. PubMed ID: 35517417
[TBL] [Abstract][Full Text] [Related]
27. Genomic instability-associated lncRNA signature predicts prognosis and distinct immune landscape in gastric cancer.
Sun J; Jiang Q; Chen H; Zhang Q; Zhao J; Li H; Wang X; Fang Y; Ruan Y; Sun Y
Ann Transl Med; 2021 Aug; 9(16):1326. PubMed ID: 34532463
[TBL] [Abstract][Full Text] [Related]
28. Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma.
Geng W; Lv Z; Fan J; Xu J; Mao K; Yin Z; Qing W; Jin Y
Front Cell Dev Biol; 2021; 9():657667. PubMed ID: 33855028
[No Abstract] [Full Text] [Related]
29. Identification of a Four-lncRNA Prognostic Signature for Colon Cancer Based on Genome Instability.
Yun D; Yang Z
J Oncol; 2021; 2021():7408893. PubMed ID: 34594379
[TBL] [Abstract][Full Text] [Related]
30. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.
Liu Z; Mi M; Li X; Zheng X; Wu G; Zhang L
J Cell Mol Med; 2020 Nov; 24(21):12444-12456. PubMed ID: 32967061
[TBL] [Abstract][Full Text] [Related]
31. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers.
Sørensen KP; Thomassen M; Tan Q; Bak M; Cold S; Burton M; Larsen MJ; Kruse TA
Breast Cancer Res; 2015 Apr; 17(1):55. PubMed ID: 25887545
[TBL] [Abstract][Full Text] [Related]
33. Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis.
Wang X; Zhang H; Ye J; Gao M; Jiang Q; Zhao T; Wang S; Mao W; Wang K; Wang Q; Chen X; Hou X; Han D
Front Genet; 2022; 13():850888. PubMed ID: 35571034
[TBL] [Abstract][Full Text] [Related]
34. A Genomic Instability-Related Long Noncoding RNA Signature for Predicting Hepatocellular Carcinoma Prognosis.
Lu J; Cao W; He Z; Wang H; Hao J; Xu J
J Oncol; 2022; 2022():3090523. PubMed ID: 36072979
[TBL] [Abstract][Full Text] [Related]
35. LncDisAP: a computation model for LncRNA-disease association prediction based on multiple biological datasets.
Wang Y; Juan L; Peng J; Zang T; Wang Y
BMC Bioinformatics; 2019 Dec; 20(Suppl 16):582. PubMed ID: 31787106
[TBL] [Abstract][Full Text] [Related]
36. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients.
Zhou M; Zhong L; Xu W; Sun Y; Zhang Z; Zhao H; Yang L; Sun J
Sci Rep; 2016 Aug; 6():31038. PubMed ID: 27503456
[TBL] [Abstract][Full Text] [Related]
37. A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma.
He Y; Li X; Meng Y; Fu S; Cui Y; Shi Y; Du H
J Cell Biochem; 2019 Oct; 120(10):16692-16702. PubMed ID: 31095790
[TBL] [Abstract][Full Text] [Related]
38. Portraying breast cancers with long noncoding RNAs.
Van Grembergen O; Bizet M; de Bony EJ; Calonne E; Putmans P; Brohée S; Olsen C; Guo M; Bontempi G; Sotiriou C; Defrance M; Fuks F
Sci Adv; 2016 Sep; 2(9):e1600220. PubMed ID: 27617288
[TBL] [Abstract][Full Text] [Related]
39. Primate-specific oestrogen-responsive long non-coding RNAs regulate proliferation and viability of human breast cancer cells.
Lin CY; Kleinbrink EL; Dachet F; Cai J; Ju D; Goldstone A; Wood EJ; Liu K; Jia H; Goustin AS; Kosir MA; Thepsuwan P; Lipovich L
Open Biol; 2016 Dec; 6(12):. PubMed ID: 28003470
[TBL] [Abstract][Full Text] [Related]
40. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
Liu D
Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
